{"schema_version":"secwatch.filing_event.v1","accession":"0001789769-24-000090","form_type":"8-K","ticker":"TIL","cik":"0001789769","company_name":"Instil Bio, Inc.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.533722+00:00","generated_at":"2026-05-31T09:03:20.992634+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Instil Bio provides SYN-2510 program overview in investor presentation","bullets":["Company furnished presentation detailing its SYN-2510 program as of August 2024.","No specific clinical data, milestones, or financial projections disclosed in the filing.","The program overview does not include any changes to previously disclosed guidance or plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001789769-24-000090","json":"https://secwatch.observer/filing/0001789769-24-000090.json","markdown":"https://secwatch.observer/filing/0001789769-24-000090.md","text":"https://secwatch.observer/filing/0001789769-24-000090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000090/0001789769-24-000090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000090/til-20240815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:03:20.992634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}